Heterogeneous subpopulations of adventitial progenitor cells regulate vascular homeostasis and pathological vascular

Austin J Jolly1, Sizhao Lu1, Keith A Strand1

  • 1Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, Aurora, CO 80045, USA.

Insights

Adventitial Sca1+ progenitor cells drive vascular remodeling in cardiovascular diseases. Understanding their heterogeneity and signaling is key to targeting these cells for therapeutic benefit.

Area of Science:

  • Vascular Biology
  • Stem Cell Biology
  • Cardiovascular Research

Background:

  • Cardiovascular diseases involve chronic vascular dysfunction and pathological remodeling.
  • Smooth muscle cells (SMCs) form neointimal lesions, but adventitial remodeling origins are unclear.
  • Adventitial Sca1+ progenitor cells (AdvSca1) are implicated in vascular remodeling.

Purpose of the Study:

  • To review the heterogeneity of Sca1+ adventitial progenitor cells.
  • To summarize their role in vascular homeostasis and pathological remodeling.
  • To discuss their translational relevance in human cardiovascular diseases.

Main Methods:

  • Review of existing literature on AdvSca1 cells in murine models.
  • Analysis of lineage-tracing studies and stem cell marker expression.
  • Examination of differentiation potential and signaling mechanisms.

Main Results:

  • AdvSca1 cells contribute to neointima formation, atherosclerosis, and fibrosis.
  • These cells exhibit multipotent differentiation into various cell types, including SMCs, endothelial cells, and macrophages.
  • Adventitial progenitor cells are heterogeneous, comprising multiple lineage-restricted subpopulations.

Conclusions:

  • AdvSca1 cells are crucial effectors of adventitial remodeling and subsequent pathological changes.
  • Targeting AdvSca1 cells offers potential therapeutic strategies for cardiovascular diseases.
  • Further research is needed to elucidate AdvSca1 cell origins and regulatory mechanisms.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.2K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.5K
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
2.9K